Open menu
Paytm Money logo
IDBI Mutual Fund

IDBI Healthcare Fund Direct - Dividend Reinvestment

NAV
returns change indicator
9.9500
as on 17 Sep 2019 08:45 PM
-0.1600(1.58%)
Last Change
loaderloader
Investment Performance
would have given a returns of
100,875
star
101,687
star
102,072
star
103,374
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
3,374
Profit (absolute return)
3.37%
in the last
1m
3m
max
+1% Higher Returns
With Direct Plans on Paytm Money
Investment Returns
In the last 3 months
3.37%
In the last 6 months
0.90%
In the last 1 year
NA
In the last 3 years
NA
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk
Scheme Information
IDBI Healthcare Fund Direct - Dividend Reinvestment
IDBI Healthcare Fund Direct - Dividend Reinvestment
as of 17 Sep 2019 08:45 PM
32.57 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 12 months.
0.89%
Expense Ratio
Plan
Dividend
26.67%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 12 months.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Jul 2019
Sort By
Healthcare
71.02%
23.13 Cr
Cash Holding
23.72%
7.73 Cr
Financial
3.54%
1.15 Cr
Chemicals
1.72%
56.03 Lakh
Sectors Holding in this Mutual Fund
as on 31 Jul 2019
Sort By
Healthcare
71.02%
23.13 Cr
Cash Holding
23.72%
7.73 Cr
Financial
3.54%
1.15 Cr
Chemicals
1.72%
56.03 Lakh
Companies Holding in this Mutual Fund
as on 31 Jul 2019
Sort By
Others
23.72%
7.73 Cr
Sun Pharmaceutical Inds. Ltd.
10.43%
3.40 Cr
Divi's Laboratories Ltd.
7.03%
2.29 Cr
Cipla Ltd.
6.57%
2.14 Cr
Aurobindo Pharma Ltd.
5.94%
1.93 Cr
Lupin Ltd.
5.78%
1.88 Cr
Sanofi India Ltd.
4.74%
1.54 Cr
Ipca Laboratories Ltd.
4.44%
1.45 Cr
Dr. Lal Pathlabs Ltd.
3.42%
1.11 Cr
Natco Pharma Ltd.
3.35%
1.09 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Jul 2019
Sort By
Others
23.72%
7.73 Cr
Sun Pharmaceutical Inds. Ltd.
10.43%
3.40 Cr
Divi's Laboratories Ltd.
7.03%
2.29 Cr
Cipla Ltd.
6.57%
2.14 Cr
Aurobindo Pharma Ltd.
5.94%
1.93 Cr
Lupin Ltd.
5.78%
1.88 Cr
Sanofi India Ltd.
4.74%
1.54 Cr
Ipca Laboratories Ltd.
4.44%
1.45 Cr
Dr. Lal Pathlabs Ltd.
3.42%
1.11 Cr
Natco Pharma Ltd.
3.35%
1.09 Cr
View All
View All
About IDBI Healthcare Fund Direct - Dividend Reinvestment
IDBI Healthcare Fund Direct - Dividend Reinvestment is a Equity mutual fund scheme from IDBI Mutual Fund. This scheme was launched on 28 Feb 2019 and is currently managed by its fund manager Uma Venkatraman. It has an AUM of ₹32.57 Crores and the latest NAV decalared is ₹9.950 as on 17 Sep 2019 at 8:45 pm.
IDBI Healthcare Fund Direct - Dividend Reinvestment scheme return performance is -0.70% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Objective
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
Scheme Details
AUM:32.57 Cr
Category:Equity: Sectoral-Pharma
Launch Date:28 Feb 2019
Fund Type:Open-End
AMC Information
IDBI Mutual Fund
IDBI Mutual Fund
View AMC Details
5,078.25 Cr
AUM
70
Schemes
Address
Address
4th Floor, IDBI Tower,WTC Complex, Cuffe Parade,Colaba,400005
Phone Number
Phone Number
Phone : 022-66442800 / 1800-419-4324
Fax : 022-66442801